Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Endpoint summary

Currently viewing:

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Referenceopen allclose all

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
19 Oct 2004 - 16 Dec 2004
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Meets national standard methods; GLP
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.2600 (Skin Sensitisation)
Deviations:
yes
Remarks:
only historical positive control, one dose tested
GLP compliance:
yes
Remarks:
Product Safety Laboratories
Type of study:
Buehler test
Justification for non-LLNA method:
A non-LLNA test is available that was performed prior to the current data requirements, stipulated in Regulation (EC) No 1907/2006. In accordance with the same Regulation, the data were included to avoid unnecessary testing.
Species:
guinea pig
Strain:
Hartley
Sex:
male
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Elm Hill Breeding Labs
- Age at study initiation: young adult
- Weight at study initiation: 310 - 418 g
- Housing: group housing in stainless steeel cages
- Diet (e.g. ad libitum): pelleted Purina guinea pig chow #5025
- Water (e.g. ad libitum): filtered tap water
- Acclimation period: 3, 6 or 40 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 - 22
- Photoperiod (hrs dark / hrs light): 12/12


IN-LIFE DATES: From: 20 Oct To: 19 Nov 2004
Route:
epicutaneous, occlusive
Vehicle:
water
Concentration / amount:
100% (undiluted, induction exposure), 75% (challenge exposure)
Route:
epicutaneous, occlusive
Vehicle:
water
Concentration / amount:
100% (undiluted, induction exposure), 75% (challenge exposure)
No. of animals per dose:
20 in test group and 10 in naive control group
Details on study design:
RANGE FINDING TESTS:
Test to determine the highest non-irrritating concentration of the test substance to be used as challenge dose. The test substance was applied in concentrations of 100, 75, 50 and 25% to the shaved test side using an occlusive Hill Top Chamber and gently removed after 6h exposure (identical to main study). Approximately 24 h after application, each site was evaluated for local irritation reactions.

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3
- Exposure period: 3 weeks
- Site: left side of each animal
- Frequency of applications: once a week
- Duration: 6 h
- Concentrations: 100%


B. CHALLENGE EXPOSURE
27 days after the first induction dose
- No. of exposures: 1
- Day(s) of challenge: 1
- Exposure period: 6 h
- Site: right side of each animal
- Concentrations: 75%
- Evaluation (hr after challenge): 24 and 48 h after the challenge application
Positive control substance(s):
yes
Remarks:
technical alpha-hexylcinnamaldehyde (historical control)
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
100%/75%
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
very faint erythema in 8/20 animals
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100%/75%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: very faint erythema in 8/20 animals.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
100%/75%
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
one animal with very faint erythema
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100%/75%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: one animal with very faint erythema.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
0%/75%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
very faint erythema in 4/10 animals
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0%/75%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: very faint erythema in 4/10 animals.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
0%/75%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0%/75%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.

The first and the second reading of the historical positive control group gave 6/10 animals with positive reactions whereas the corresponding negative control group (5 animals) gave no reactions at both time points.

Interpretation of results:
not sensitising
Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
yes
Remarks:
1-fluoro-2,4-dinitrobenzene (DNFB) as positive  control
GLP compliance:
not specified
Type of study:
mouse local lymph node assay (LLNA)
Species:
mouse
Strain:
Balb/c
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS: 
- Source: National Cancer Institute, USA
- Age: 45 - 60 days
- Weight at study initiation: 17 - 20 g
Vehicle:
other: 15% ethanol
Concentration:
2, 4 and 6%
Details on study design:
RANGE FINDING TESTS:
- Irritation: A primary irritancy assay was performed to establish the  minimal irritating and the maximal non-irritating concentration.

TREATMENT PREPARATION AND ADMINISTRATION:
Test solutions were  prepared daily in amber vials using 15% ethanol.
Positive control substance(s):
other: 1-fluoro-2,4-dinitrobenzene (DNFB)
Statistics:
Bartlett's chi-square Test, one-way ANOVA and  Dunnett's Multiple Range t Test
Remarks on result:
other: please refer to 'any other information on results incl. tables'

RESULTS OF PILOT STUDY: minimal irritating concentration: 6%; maximal  non-irritating concentration: 4%

 
RESULTS OF TEST
- Sensitization reaction: sensitization with 2-6% did not significantly  alter cell proliferation in the auricular lymph nodes,

even though an  increase of 30% and 40% at the 4% and 6% treatment levels was measured,  respectively. A greater than

30-fold increase was measured in the  positive control.

Interpretation of results:
not sensitising
Endpoint conclusion
Additional information:

Potassium silicate as well as the read-across substance, sodium metasilicate, were not sensitizing in two different skin sensitisation tests (Buehler test and local lymph node assay). In a human case report, contact urticaria induced by sodium silicate was observed in one individual.


Migrated from Short description of key information:
Potassium silicate is not sensitising.

Respiratory sensitisation

Endpoint conclusion
Additional information:

Not required. No data available.

Justification for classification or non-classification

The available data is conclusive but not sufficient for classification.